---

---

FDA is announcing a virtual public meeting to discuss proposed recommendations for the reauthorization of the Generic Drug User Fee Amendments for fiscal years 2023 through 2027.  The virtual public meeting will be held on November 16, 2021, from 9 a.m. to 2 p.m. ET. The meeting agenda, public docket information, additional materials, and any other updates will also be posted to this website as they become available.   
 
You can register for the meeting here​. Registration is not required to view the meeting, however, registrants will receive email updates and notices when new information becomes available. If you wish to present during a public comment session, please submit your request to [email protected] by 11:59 p.m. ET on November 8, 2021. 

Date: November 16, 2021 

Time: 9:00 AM - 2:00 PM ET 

Webinar Information: 
Zoom meeting link

Webinar Meeting ID: 
160 003 0426 

Webinar Password (Case-Sensitive): 
GDUFa3!

Federal Register Notice

Event Materials

• Webinar Recording of GDUFA III Public Meeting

---